000273929 001__ 273929
000273929 005__ 20250120102327.0
000273929 0247_ $$2doi$$a10.1182/blood-2024-209569
000273929 0247_ $$2ISSN$$a0006-4971
000273929 0247_ $$2ISSN$$a1528-0020
000273929 037__ $$aDZNE-2024-01403
000273929 082__ $$a610
000273929 1001_ $$aArner, Anja$$b0
000273929 1112_ $$a66th American Society of Hematology Annual Meeting$$cSan Diego$$d2024-12-07 - 2024-12-10$$gASH$$wUSA
000273929 245__ $$aALL-R: An Anchoring Score to Predict Relapse in Acute Lymphoblastic Leukemia (ALL) Using a Zebrafish Patient-Derived Xenograft Model
000273929 260__ $$aWashington, DC$$bAmerican Society of Hematology$$c2024
000273929 300__ $$a275
000273929 3367_ $$2ORCID$$aCONFERENCE_PAPER
000273929 3367_ $$033$$2EndNote$$aConference Paper
000273929 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$mjournal
000273929 3367_ $$2BibTeX$$aINPROCEEDINGS
000273929 3367_ $$2DRIVER$$aconferenceObject
000273929 3367_ $$2DataCite$$aOutput Types/Conference Paper
000273929 3367_ $$0PUB:(DE-HGF)8$$2PUB:(DE-HGF)$$aContribution to a conference proceedings$$bcontrib$$mcontrib$$s1736775175_13802
000273929 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000273929 588__ $$aDataset connected to CrossRef, Journals: pub.dzne.de
000273929 7001_ $$aBlaser, Bradley Wayne$$b1
000273929 7001_ $$aEttinger, Andreas$$b2
000273929 7001_ $$0P:(DE-2719)2241638$$aSchmid, Bettina$$b3$$udzne
000273929 7001_ $$aJeremias, Irmela$$b4
000273929 7001_ $$aBinder-Blaser, Vera$$b5
000273929 773__ $$0PERI:(DE-600)1468538-3$$a10.1182/blood-2024-209569$$gVol. 144, no. Supplement 1, p. 275 - 275$$nSupplement 1$$p275$$tBlood$$v144$$x0006-4971$$y2024
000273929 8564_ $$uhttps://pub.dzne.de/record/273929/files/DZNE-2024-01403_Restricted.pdf
000273929 8564_ $$uhttps://pub.dzne.de/record/273929/files/DZNE-2024-01403_Restricted.pdf?subformat=pdfa$$xpdfa
000273929 909CO $$ooai:pub.dzne.de:273929$$pVDB
000273929 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2241638$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000273929 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000273929 9141_ $$y2024
000273929 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBLOOD : 2022$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000273929 915__ $$0StatID:(DE-HGF)9920$$2StatID$$aIF >= 20$$bBLOOD : 2022$$d2023-10-21
000273929 9201_ $$0I:(DE-2719)1140002$$kAG Schmid München$$lGenetic Models of Neurodegeneration$$x0
000273929 980__ $$acontrib
000273929 980__ $$aVDB
000273929 980__ $$ajournal
000273929 980__ $$aI:(DE-2719)1140002
000273929 980__ $$aUNRESTRICTED